Browse > Article

Intra-arterial Direct Prostaglandin Infusion Combined with Lower Limb Arterial Bypass Graft and Lumbar Sympathectomy for Treating Buerger's Disease  

Yie, Kil-Soo (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital)
Ryu, Se-Min (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital)
Cho, Seong-Joon (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital)
Lee, Seo-Young (Department of Neurology, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital)
Publication Information
Journal of Chest Surgery / v.41, no.4, 2008 , pp. 508-511 More about this Journal
Abstract
The incidence of the Buerger's disease is higher for the far-East Asian population that for western people, but the surgical outcomes have been documented to be unsatisfactory. So, more aggressive and multi-focused treatment modalities should be warranted such as stopping smoking or intravenous vasodilator infusion with surgery. We report here on a successful surgical case of intra-arterial direct infusion of Prostaglandin E1 concomitant with surgical bypass and lumbar sympathectomy to treat Buerger's disease.
Keywords
Prostaglandin E; Sympathectomy; Buerger's disease;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jeffry WO. Thromboangitis obliterans: rutherford. Vascular Surgery. 6th ed. Philadelphia: Elsevier Saunders Co. 2005.
2 De Giacomo T, Rendina EA, Venuta F. Thoracoscopic sympathectomy for symptomatic arterial obstruction of the upper extremities. Ann Thorac Surg 2002;74:885-8.   DOI   ScienceOn
3 Park JS, Kim KU. Buerger's disease in Korea. Korean J Vasc Surg 2005;21:105-12.
4 Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger's disease in Japan. Surgery 1998;124:498-502.   DOI   PUBMED   ScienceOn
5 The European TAO Study Group. Oral iloprost in the treatment of thromboangitis obliterans (Buerger' s disease): a double-blind, radomised, placebo-controlled trail. Euro J Vasc Surg 1998;15:300-6.   DOI   ScienceOn
6 Shionoya S. Buerger's disease: Diagnosis and management. Cardiovasc Surg 1993;1:207-15.   PUBMED
7 Okuda Y, Kitajima T. The effects of combined sympathetic block and intravascular infusion of prostaglandin E1 on brachial arterial blood flow in dogs. Anesth Analg 1999; 89:1514-6.   DOI   ScienceOn
8 Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential on peripheral vascular disease, myocardial ischemia andd extracorporeal circulation procedures. Drugs 1992;43: 889-95.   DOI   ScienceOn